Abstract:Although iodinated contrast agents are safe and widely used, adverse events occur and questions remain about their use, safety, and interactions. Some questions are easily answered and others still require extensive investigation. For one frequent question--is informed consent necessary before all contrast media injections--the simple answer is no. Another question concerns use of contrast media in patients with prior reactions or allergies. Contrast agents can be safely used in such patients, but special care must be taken to be aware of what the previous reaction was and to be ready to treat any reaction. The protective role of pre-treatment with steroids is well established for minor reactions, but they may not prevent major reactions. It is important to realize that even life-threatening, anaphylactoid reactions are not the result of a true allergy to contrast media. Many questions arise about contrast agent-induced nephropathy. Baseline serum creatinine values should be obtained in patients who are at risk, not all patients. The incidence and natural history of contrast agent-induced nephropathy remain unclear. It occurs only in patients with compromised renal function before contrast agent injection, but even patients with normal serum creatinine levels can have renal dysfunction. Calculated creatinine clearance is a better way to determine risk and to follow this complication. The outcome in almost all patients is benign, with progression to end-stage renal disease being rare. The major risk factors, in addition to renal dysfunction, are long-standing diabetes mellitus, dehydration, and use of other nephrotoxic medications. Recent work in preventing and ameliorating contrast agent-induced nephropathy with N-acetyl cysteine, substitution of an isosmolal nonionic contrast agent, and various hydration regimens has been promising. Another common concern is use of iodinated contrast agents in pregnant or breast-feeding women. In both cases, there is no evidence of harm to the fetus or infant, but it is prudent to weigh the theoretical risks and benefits and avoid contrast agent administration unless it is truly necessary.

Prevention and Treatment of Anaphylactoid Reaction to Ionic and Nonionic Iodinated Contrast Media

Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media

Anaphylactic risk associated with iodinated and gadolinium-based contrast media

Iodine and Gadolinium Contrast Reactions: What Is the Risk and Role of Premedication, Abbreviated Protocols, Prior History of Reactions, and Cross-Reactivity?

Adverse reactions to radiological contrast media: Prevention and treatment

[Complications related to the administration of iodinated contrast media]

Managing Adverse Reactions to Contrast Agents

[Contrast medium: an unpredictable ally]

[Prophylaxis and treatment of side effects due to iodinated contrast media relevant to radiological practice]

Risk factors and recent advances in the prevention of contrast - induced nephropathy

Adverse Reactions after the Use of SonoVue Contrast Agent

Adverse Reactions to Contrast Material: A Canadian Update

Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis

Shelling the myth: allergies to Iodine containing substances and risk of reaction to Iodinated contrast media

Frequently Asked Questions: Iodinated Contrast Agents

Management of acute adverse reactions to contrast media

Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China

Iodinated Contrast Media and Their Adverse Reactions

Contrast media safety-an update

Management of acute coronary syndromes requiring coronary angiography in patients with drug reaction with eosinophilia and systemic symptoms syndrome induced by iodinated contrast media: two case reports and narrative review

Safety Evaluation and Risk Management of Iohexol Injection